Krisky D - Search Results

1

Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model.

Gómez-Navarro J, Contreras JL, Arafat W, Jiang XL, Krisky D, Oligino T, Marconi P, Hubbard B, Glorioso JC, Curiel DT, Thomas JM. Gómez-Navarro J, et al. Among authors: krisky d. Gene Ther. 2000 Jan;7(1):43-52. doi: 10.1038/sj.gt.3301054. Gene Ther. 2000. PMID: 10680015

2

Rapid method for construction of recombinant HSV gene transfer vectors.

Krisky DM, Marconi PC, Oligino T, Rouse RJ, Fink DJ, Glorioso JC. Krisky DM, et al. Gene Ther. 1997 Oct;4(10):1120-5. doi: 10.1038/sj.gt.3300497. Gene Ther. 1997. PMID: 9415320

3

Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.

Suzuki T, Piche A, Kasono K, Xiang J, Gomez-Navarro J, Moriuchi S, Krisky DM, Oligino T, Glorioso JC, Curiel TJ, Curiel DT. Suzuki T, et al. Among authors: krisky dm. Biochem Biophys Res Commun. 1998 Nov 27;252(3):686-90. doi: 10.1006/bbrc.1998.9685. Biochem Biophys Res Commun. 1998. PMID: 9837767

4

Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications.

Krisky DM, Marconi PC, Oligino TJ, Rouse RJ, Fink DJ, Cohen JB, Watkins SC, Glorioso JC. Krisky DM, et al. Gene Ther. 1998 Nov;5(11):1517-30. doi: 10.1038/sj.gt.3300755. Gene Ther. 1998. PMID: 9930305

5

Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons.

Krisky DM, Wolfe D, Goins WF, Marconi PC, Ramakrishnan R, Mata M, Rouse RJ, Fink DJ, Glorioso JC. Krisky DM, et al. Gene Ther. 1998 Dec;5(12):1593-603. doi: 10.1038/sj.gt.3300766. Gene Ther. 1998. PMID: 10023438

6

Connexin 43-enhanced suicide gene therapy using herpesviral vectors.

Marconi P, Tamura M, Moriuchi S, Krisky DM, Niranjan A, Goins WF, Cohen JB, Glorioso JC. Marconi P, et al. Among authors: krisky dm. Mol Ther. 2000 Jan;1(1):71-81. doi: 10.1006/mthe.1999.0008. Mol Ther. 2000. PMID: 10933914 Free article.

7

HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.

Moriuchi S, Krisky DM, Marconi PC, Tamura M, Shimizu K, Yoshimine T, Cohen JB, Glorioso JC. Moriuchi S, et al. Among authors: krisky dm. Gene Ther. 2000 Sep;7(17):1483-90. doi: 10.1038/sj.gt.3301265. Gene Ther. 2000. PMID: 11001368

8

High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type 1 vector.

Wang M, Rancourt C, Navarro JG, Krisky D, Marconi P, Oligino T, Alvarez RD, Siegal GP, Glorioso JC, Curiel DT. Wang M, et al. Among authors: krisky d. Gynecol Oncol. 1998 Nov;71(2):278-87. doi: 10.1006/gyno.1998.5132. Gynecol Oncol. 1998. PMID: 9826472

9

Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis.

Oligino T, Ghivizzani S, Wolfe D, Lechman E, Krisky D, Mi Z, Evans C, Robbins P, Glorioso J. Oligino T, et al. Among authors: krisky d. Gene Ther. 1999 Oct;6(10):1713-20. doi: 10.1038/sj.gt.3301014. Gene Ther. 1999. PMID: 10516720

10

Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo.

Marconi P, Simonato M, Zucchini S, Bregola G, Argnani R, Krisky D, Glorioso JC, Manservigi R. Marconi P, et al. Among authors: krisky d. Gene Ther. 1999 May;6(5):904-12. doi: 10.1038/sj.gt.3300882. Gene Ther. 1999. PMID: 10505116

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page